CITI PHARMA Sustainability Profile
CITI PHARMA, a leading pharmaceutical company headquartered in Pakistan, has established itself as a key player in the healthcare industry since its inception in 1994. With a strong operational presence across various regions, the company focuses on the development, manufacturing, and marketing of high-quality pharmaceutical products. CITI PHARMA is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and specialised formulations. The company’s commitment to innovation and quality has earned it a reputable position in the market, marked by several key milestones in research and development. With a dedication to improving patient outcomes, CITI PHARMA continues to expand its reach and enhance its product offerings, solidifying its status as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does CITI PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CITI PHARMA's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CITI PHARMA's reported carbon emissions
CITI PHARMA, headquartered in Pakistan (PK), currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, Scope 2, and Scope 3 emissions, are not provided. In terms of climate commitments, CITI PHARMA has not outlined any specific reduction targets or initiatives. There are no documented science-based targets (SBTi) or other climate pledges that indicate a commitment to reducing carbon emissions at this time. The absence of emissions data and reduction initiatives suggests that CITI PHARMA may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for CITI PHARMA to establish clear targets and reporting mechanisms to align with global climate goals.
How Carbon Intensive is CITI PHARMA's Industry?
How Carbon Intensive is CITI PHARMA's Location?
CITI PHARMA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CITI PHARMA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
